Loading...

APC anti-mouse CD31 Antibody

Pricing & Availability
Clone
MEC13.3 (See other available formats)
Regulatory Status
RUO
Other Names
PECAM-1, EndoCAM
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
MEC13dot3_APC_072808.jpg
C57BL/6 splenocytes stained with MEC13.3 APC
  • MEC13dot3_APC_072808.jpg
    C57BL/6 splenocytes stained with MEC13.3 APC
Compare all formats See APC spectral data
Cat # Size Price Save
102509 25 µg ¥18,400
102510 100 µg ¥60,930
Description

CD31 is a 130-140 kD glycoprotein, also known as platelet endothelial cell adhesion molecule (PECAM-1), EndoCAM, and gpIIa. It is a member of the Ig superfamily, expressed on endothelial cells, platelets, granulocytes, monocytes/macrophages, dendritic cells, and T and B cell subsets, and is critical for cell-to-cell interactions. The primary ligands for CD31 have been reported to be CD38 and the vitronectin receptor (αv β3 integrin, CD51/CD61). Other reported functions of CD31 are neutrophil emigration to sites of inflammation, and angiogenesis.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Polyoma middle T transformed EC line tEnd.1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Anti-mouse CD31 clones 390 and MEC13.3 bind to their respective non-overlapping epitopes in IgD2 of CD31.8 Additional reported applications (in the relevant formats) include: immunoprecipitation1, in vitro and in vivo blocking of CD31-mediated cell-cell interactions1-4, immunohistochemical staining1,5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)12,13.
Special Note: The antibody works well on acetone-fixed frozen sections as well as Zinc-fixed paraffin-embedded sections. It sometime works on formalin-fixed and paraformaldehyde-fixed paraffin-embedded tissue sections but inconsistent results have been reported. This antibody is not recommended for formalin-fixed paraffin-embedded sections or for Western blot analysis. The Ultra-LEAF™ Purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 102529 and 102530).

Application References

(PubMed link indicates BioLegend citation)
  1. Vecchi A, et al. 1994. Eur. J. Cell Biol. 63:247. (IP, IHC, Block)
  2. Christofidou-Solomidou M, et al. 1997. J. Immunol. 158:4872. (Block)
  3. DeLisser HM, et al. 1997. Am. J. Pathol. 151:671. (Block)
  4. Rosenblum WI, et al. 1994. Am. J. Pathol. 145:33. (Block)
  5. Baldwin HS, et al. 1994. Development 120:2539. (IHC)
  6. Voswinckel R, et al. 2003. Circ. Res. 93:372. (IHC)
  7. Leung VW, et al. 2009. Am J. Pathol. 175:1757. PubMed
  8. Chacko AM, et al. 2012. PLoS One 7:e34958.
  9. Giacomini C, et al. 2014. Exp Eye Res. 18:1. PubMed
  10. Morita R, et al. 2015. PNAS. 112:160. PubMed
  11. Ito A, et al. 2015. Brain Res. 1594:310. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. J Gautam, X Zhang, Y Yao 2016. Sci Rep. 6:36450. PubMed
  2. Wang L, et al. 2018. Bone Res. 6:22. PubMed
  3. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  4. Kataru RP, et al. 2021. Sci Signal. 14:. PubMed
  5. Almada AE, et al. 2021. Cell Reports. 34(4):108656. PubMed
  6. Cayre S, et al. 2020. Development. 147:00:00. PubMed
  7. Mourao L, et al. 2019. Sci Rep. 0.991666667. PubMed
  8. Concepcion CP, et al. 2022. Cancer Discov. 12:562. PubMed
  9. Ahmed M, et al. 2016. Development. 143: 1663 - 1673. PubMed
  10. Del Priore I, et al. 2021. STAR Protocols. 2(2):100583. PubMed
  11. Wang M, et al. 2022. Theranostics. 12:4513. PubMed
  12. Watanabe C, et al. 2022. Life (Basel). 12:. PubMed
  13. Chiche A, et al. 2016. Oncogene. 10.1038/onc.2016.396. PubMed
  14. Bajwa A, et al. 2014. J Am Soc Nephrol. 26:908. PubMed
  15. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  16. Lubkin A et al. 2019. Cell host & microbe. 25(3):463-470 . PubMed
  17. Romagnoli M, et al. 2020. Development. 147:. PubMed
  18. Wang X, et al. 2022. Nat Aging. 2:155. PubMed
  19. Romagnoli M, et al. 2019. Stem Cell Reports. 1.077083333. PubMed
  20. Khateb M, et al. 2022. Cell Rep. 40:111219. PubMed
  21. Xu Q, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  22. Lafkas D, et al. 2013. J Cell Biol. 203:47. PubMed
  23. Gao X, et al. 2013. J Exp Med. 210:2833. PubMed
  24. LaFave LM, et al. 2020. Cancer Cell. 38(2):212-228.e13. PubMed
  25. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  26. Bresson L, et al. 2018. Development. 145. PubMed
  27. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  28. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  29. Auvinen K, et al. 2019. Sci Rep. 9:15698. PubMed
  30. Rantakari P, et al. 2016. Nature. 538:392-396. PubMed
  31. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  32. Umezawa Y, et al. 2017. J Biol Chem. 292:19639. PubMed
  33. Durré T, et al. 2018. Nat Commun. 9:5178. PubMed
  34. Chiche A, et al. 2019. Breast Cancer Res. 21:13. PubMed
  35. Sacma M, et al. 2022. STAR Protoc. 3:101483. PubMed
  36. Mueller A, et al. 2016. Nature. 540:276-279. PubMed
  37. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  38. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  39. Ishikura S, et al. 2021. J Cell Biochem. . PubMed
  40. Wenzel J, et al. 2020. Arterioscler Thromb Vasc Biol. 40:2837. PubMed
  41. Peuhu E, et al. 2017. EMBO J. 36(2):165-182. PubMed
  42. Fukushima K, et al. 2020. Immunity. 52(3):542-556. PubMed
  43. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  44. He H, et al. 2021. JCI Insight. 6:. PubMed
  45. Elias S, et al. 2015. PLoS Biol. 13:1002142. PubMed
  46. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  47. Bruno C, et al. 2020. Brain Commun. 2:fcaa133. PubMed
  48. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  49. Adachi K et al. 2018. Cell stem cell. 23(2):266-275 . PubMed
  50. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  51. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  52. Sarshad AA, et al. 2018. Mol Cell. 71:1040. PubMed
  53. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  54. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  55. Cayre S, et al. 2020. Development. . PubMed
  56. Bochenek ML, et al. 2022. JCI Insight. 7:. PubMed
RRID
AB_312916 (BioLegend Cat. No. 102509)
AB_312917 (BioLegend Cat. No. 102510)

Antigen Details

Structure
Ig superfamily, 130-140 kD
Distribution

Endothelial cells, platelets, granulocytes, monocytes/macrophages, dendritic cells, T and B cell subsets

Function
Adhesion
Ligand/Receptor
CD38, αV/β3 integrin
Cell Type
B cells, Dendritic cells, Endothelial cells, Granulocytes, Macrophages, Monocytes, Neutrophils, Platelets, T cells
Biology Area
Angiogenesis, Cell Adhesion, Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. DeLisser HM, et al. 1994. Immunol. Today 15:490.
3. Newman PJ, et al. 1990. Science 247:1219.

Gene ID
18613 View all products for this Gene ID
UniProt
View information about CD31 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 07/19/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account